Product
mercaptopurine
Aliases
6-MP
Name
Mercaptopurine
INN Name
mercaptopurine
FDA Approved
Yes
5 clinical trials
4 organizations
6 indications
2 documents
Indication
LeukemiaIndication
Childhood Acute Lymphoblastic LeukemiaIndication
Langerhans Cell HistiocytosisIndication
MucositisIndication
Oral ComplicationsClinical trial
Phase III Randomized Trial of Autologous and Allogeneic Stem Cell Transplantation Versus Intensive Conventional Chemotherapy in Acute Lymphoblastic Leukemia in First RemissionStatus: , Estimated PCD: 2006-12-01
Clinical trial
Intensive Treatment for Intermediate-Risk Relapse of Childhood B-precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine StrategiesStatus: , Estimated PCD: 2016-03-01
Clinical trial
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell HistiocytosisStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
ALinC 17: Protocol for Patients With Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL): A Phase III StudyStatus: Completed, Estimated PCD: 2005-07-01
Clinical trial
A Randomized Trial for Adults With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Document
DailyMed Label: MercaptopurineOrganization
Hikma Pharmaceuticals USA Inc.Organization
Mylan Pharmaceuticals Inc.Document
DailyMed Label: PURINETHOLOrganization
Stason Pharmaceuticals, Inc.Organization
Quinn Pharmaceuticals